Evidence map›Paper›PMID 41590847›Full record

ArticleJournal of cardiovascular development and disease2025

Etiology of Coronary Reintervention After Coronary Artery Bypass Surgery.

Ikram Achbar, De Qing F N Görtzen, Joost F J Ter Woorst, Koen Teeuwen, Pim A L Tonino, Ferdi Akca

Abstract read
In one paragraph

Article in Journal of cardiovascular development and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ikram AchbarDepartment of Cardiothoracic Surgery, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.ORCID 0000-0001-6578-8167
De Qing F N GörtzenDepartment of Cardiothoracic Surgery, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.ORCID 0009-0001-4934-8249
Joost F J Ter WoorstDepartment of Cardiothoracic Surgery, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.ORCID 0000-0003-1886-4045
Koen TeeuwenDepartment of Interventional Cardiology, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.ORCID 0000-0002-1530-5187
Pim A L ToninoDepartment of Interventional Cardiology, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.
Ferdi AkcaDepartment of Cardiothoracic Surgery, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.ORCID 0009-0001-1273-8876

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Coronary artery bypass grafting (CABG) reduces the risk of target vessel revascularization compared to percutaneous coronary intervention (PCI), yet coronary reintervention may still occur. This study aims to evaluate the incidence and underlying etiology of reintervention after CABG. (2) Methods: A single-center retrospective cohort study of all patients undergoing isolated CABG (January 2016-December 2021) was performed. Surgical or percutaneous reinterventions were analyzed until December 2022 using institutional data linked to the Netherlands Heart Registration (NHR) and chart review. (3) Results: Amongst 4814 patients, 8.7% (n = 418) underwent coronary reintervention during a median 4.5 [3.8-4.8] year follow-up. Causes of reintervention included graft failure (64.6%), progression of coronary artery disease (20.3%), incomplete revascularization (10.5%), or combined factors (4.1%). Mortality did not differ significantly between reintervention and non-reintervention groups (10.8% vs. 7.9%,

Indexed as

coronary artery bypass graftinggraft failureincomplete revascularizationprogression of diseasereintervention

Identifiers

PMID41590847
PMCPMC12842345

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.